The buyer wants us to roll fifteen percent of our transaction proceeds into their parent entity, but they are valuing their stock using a massive forward multiple while valuing our business on a trailing multiple. How do we call out this valuation arbitrage and level the playing field?

Question

Tyler Smith · Accepted Answer

This is a classic valuation arbitrage play. Private equity groups and strategic buyers love to buy small businesses at low trailing EBITDA multiples and convince the sellers to roll equity into the parent company valued at a premium forward multiple. They are essentially trading cheap, hard cash for expensive, hypothetical paper. You must force a symmetric valuation methodology.

Use the regression-based valuation model principles outlined in the Ankura framework. Demand that both entities be valued using the same financial metrics and timeframes. If the buyer insists on valuing their parent company using forward-looking multiples, then your business must also be valued on its forward-looking, AI-optimized projections under the IVS 105 Income Approach.

Alternatively, if they insist on valuing your business on a trailing twelve-month basis, then their parent company equity must be priced on a trailing basis as well.

Build this demand into your negotiations as a matter of alignment and trust. Explain that a true partnership requires a level playing field. If they refuse to align the valuation methodologies, negotiate for protective structural terms on your rolled equity, such as liquidation preferences, put options that force them to buy you out at a set multiple if certain milestones are missed, or anti-dilution provisions. This prevents them from diluting your equity stake or inflating their own paper value at your expense.